Ailon Pharma Oy

OYActive

Y-tunnus 3157653-9Tykistökatu 4A-4565, 20520 TurkuWholesale of pharmaceutical and medical goods · NACE 4646Est. 20202 employeeswww.ailonpharma.fi

Overview Financials People & ownership Related companies

Ailon Pharma Oy is a Finnish OY based in Turku, operating in the Lääkkeiden tukkukauppa sector. Incorporated in 2020, the company has 2 employees and reported revenue of EUR 867K in its latest annual filing.

Revenue 2025

EUR 867K

+32% vs 2024

EBITDA margin

18.3%

+143% vs 2024

Equity ratio

20.6%

Financial strength

Net profit 2025

EUR 55K

+138% vs 2024

EBITDA — year on year

EUR millions

Key figures

Annual report 2025

Revenue	EUR 867K	+32%
EBITDA	EUR 158K	+143%
Net profit	EUR 55K	+138%
Total assets	EUR 495K	+54%
Equity	EUR 102K	+110%
Employees	2	—

Contact

Address

Tykistökatu 4A-4565, 20520 Turku

Phone

+358407024992

sami.nikoskelainen@ailonpharma.fi

Website

www.ailonpharma.fi

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Y-tunnus number of Ailon Pharma Oy?

Ailon Pharma Oy is registered with PRH / YTJ under Y-tunnus 3157653-9.

What is the revenue of Ailon Pharma Oy?

Ailon Pharma Oy reported revenue of EUR 867K in 2025.

How many employees does Ailon Pharma Oy have?

Ailon Pharma Oy employs 2 people as of the latest annual report.

Who is the CEO of Ailon Pharma Oy?

Eero Johannes Nikoskelainen is Deputy Member of Ailon Pharma Oy, in role since 2020.

Who is the chairman of Ailon Pharma Oy?

Marianna Mirjami Nikoskelainen chairs the board of Ailon Pharma Oy, in role since 2020.

Where is Ailon Pharma Oy headquartered?

Ailon Pharma Oy's registered address is Tykistökatu 4-A565.

Ailon Pharma Oy

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Ailon Pharma Oy

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Ailon Pharma Oy